KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) Research & Development (2018 - 2025)

Steris (STE) has 8 years of Research & Development data on record, last reported at $27.6 million in Q1 2025.

  • For Q1 2025, Research & Development rose 0.68% year-over-year to $27.6 million; the TTM value through Mar 2025 reached $107.6 million, up 2.4%, while the annual FY2025 figure was $107.6 million, 3.83% up from the prior year.
  • Research & Development reached $27.6 million in Q1 2025 per STE's latest filing, up from $27.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $27.6 million in Q1 2025 and bottomed at $17.5 million in Q1 2021.
  • Average Research & Development over 5 years is $24.4 million, with a median of $24.9 million recorded in 2022.
  • Peak YoY movement for Research & Development: soared 51.01% in 2021, then dropped 6.17% in 2023.
  • A 5-year view of Research & Development shows it stood at $24.8 million in 2021, then rose by 2.78% to $25.5 million in 2022, then increased by 1.56% to $25.9 million in 2023, then increased by 5.58% to $27.4 million in 2024, then rose by 1.06% to $27.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $27.6 million in Q1 2025, $27.4 million in Q4 2024, and $27.0 million in Q3 2024.